Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001).
about
Complementary and synergistic therapeutic effects of compounds found in Kampo medicine: analysis of daikenchutoClinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: a randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902).Multicentre, randomised, placebo-controlled trial of extract of Japanese herbal medicine Daikenchuto to prevent bowel dysfunction after adult liver transplantation (DKB 14 Study)Intestinal, portal, and peripheral profiles of daikenchuto (TU-100)'s active ingredients after oral administration.Daikenchuto (TU-100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K.Dai-Kenchu-To, a Herbal Medicine, Attenuates Colorectal Distention-induced Visceromotor Responses in Rats.Depolarizing Effects of Daikenchuto on Interstitial Cells of Cajal from Mouse Small Intestine.Transient receptor potential ankyrin 1 agonists improve intestinal transit in a murine model of postoperative ileus.Daikenchuto (TU-100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and withdrawalEffect of Daikenchuto (TJ-100) on gastrointestinal symptoms following laparoscopic colectomy in patients with colon cancer: study protocol for a randomized controlled trial.Clinical pharmacology of daikenchuto assessed by transit analysis using radiopaque markers in patients with colon cancer undergoing open surgery: a multicenter double-blind randomized placebo-controlled study (JFMC39-0902 additional study).The effect of Daikenchuto on postoperative intestinal motility in patients with right-side colon cancer.Time-, Sex-, and Dose-Dependent Alterations of the Gut Microbiota by Consumption of Dietary Daikenchuto (TU-100).Meta-analysis of randomized controlled trials on the efficacy of daikenchuto on improving intestinal dysfunction after abdominal surgery.Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PD
P2860
Q26795516-8F94CB65-0DC5-477B-8598-84BB653185F8Q35798344-383A6C25-F2A7-4DA7-8594-8768726D3333Q36120517-3F15B097-52ED-4A03-BFA2-8B67C99FC055Q36201537-2D6EBD95-2F81-46D5-8048-E3578972C9FAQ36648890-404E801E-080D-49E0-8959-73E481B54EACQ37324433-B2EB708E-6710-4DDF-86DB-E303719371D6Q37640792-DF16DB7F-9610-4188-BC7B-E923A61E8F6DQ38765361-F3ED4141-2912-46CC-859B-EBC73B9F47A9Q42285679-C22DAEB0-71CA-4B25-9E26-60AE2560CD8BQ47140628-A5503D51-9CF1-45CB-BB63-B009936A312CQ53432185-0D94C422-E4A5-4585-B120-890F1E015B48Q54399199-D3BF7038-BB54-4F22-A287-DF2EB80086AAQ55129833-2527EA29-FC5B-413A-A000-A9912264901FQ55420391-2D9CEFB8-F9BE-4B79-AC3A-924CAF76452AQ58573108-4C97B3B1-CAE2-420B-B0B8-04E56C129CD2
P2860
Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Effect of TU-100, a traditiona ...... phase III trial (JFMC40-1001).
@en
Effect of TU-100, a traditiona ...... phase III trial (JFMC40-1001).
@nl
type
label
Effect of TU-100, a traditiona ...... phase III trial (JFMC40-1001).
@en
Effect of TU-100, a traditiona ...... phase III trial (JFMC40-1001).
@nl
prefLabel
Effect of TU-100, a traditiona ...... phase III trial (JFMC40-1001).
@en
Effect of TU-100, a traditiona ...... phase III trial (JFMC40-1001).
@nl
P2093
P2860
P1476
Effect of TU-100, a traditiona ...... phase III trial (JFMC40-1001).
@en
P2093
Etsuro Hatano
Hiroaki Nagano
Junichi Sakamoto
Masaki Kitajima
Masaru Miyazaki
Mitsuo Kusano
Mitsuo Shimada
Satoshi Morita
Shigetoyo Saji
Takashi Kaiho
P2860
P2888
P304
P356
10.1007/S10147-014-0678-2
P577
2014-03-06T00:00:00Z